Get started
Author

Eryan Yang

FUNDC1-dependent mitophagy induced by tPA protects neurons against cerebral ischemia-reperfusion injury
2020 · Ying Cai, Eryan Yang, et al. · Redox Biology · 198
Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A
2022 · Weili Jin, Jixing Zhao, et al. · Theranostics · 104
PDF
Phosphatidylcholine‐Engineered Exosomes for Enhanced Tumor Cell Uptake and Intracellular Antitumor Drug Delivery
2021 · Qi Zhan, Kaikai Yi, et al. · Macromolecular Bioscience · 74
HIF1α/ATF3 partake in PGK1 K191/K192 succinylation by modulating P4HA1/succinate signaling in glioblastoma
2024 · Shixue Yang, Qi Zhan, et al. · Neuro-Oncology · 67
A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma
2022 · Jixing Zhao, Shixue Yang, et al. · Neuro-Oncology · 66
PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma
2022 · Kaikai Yi, Xiaoteng Cui, et al. · Frontiers in Immunology · 55
PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma
2022 · Eryan Yang, Lin Wang, et al. · Theranostics · 49
PDF
Tissue plasminogen activator disrupts the blood-brain barrier through increasing the inflammatory response mediated by pericytes after cerebral ischemia
2019 · Eryan Yang, Ying Cai, et al. · Aging · 30
Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke
2021 · Weili Jin, Ye Wu, et al. · Theranostics · 28
PDF
EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma
2024 · Eryan Yang, Biao Hong, et al. · Cancer Letters · 27
EPIC-1042 as a potent PTRF/Cavin1–caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma
2023 · Biao Hong, Eryan Yang, et al. · Neuro-Oncology · 20
RETRACTED: Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma
2021 · Ye Wu, Weili Jin, et al. · Molecular Therapy · 15
PDF
Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in glioma
2025 · Dongyuan Su, Biao Hong, et al. · Acta Pharmaceutica Sinica B · 6
Universal theranostic CRISPR/Cas13a RNA-editing system for glioma
2023 · Ye Wu, Yunfei Wang, et al. · Theranostics · 6
PDF
AQB improves carboplatin sensitivity in endometrial cancer through dual DNA repair modulation: suppression of the p21-E2F1-RAD51 and ATF3-HDAC1-BRCA1 signaling
2025 · Xingyu Zheng, Eryan Yang, et al. · Cell Death and Disease · 5
The Value of Integrating Hormone Receptors into Immunohistochemistry-Based Simplified Molecular Classification in Endometrial Cancer
2025 · Shuangshuang Zhao, Ye Yan, et al. · Cancer Management and Research · 3
PDF
NEU1 sustains mitochondria-lysosome contacts to trigger lysosomal Cu²+/cathepsin escape and mitochondrial lysis in glioblastoma (NeuLysis)
2026 · Yanping Huang, Dongyuan Su, et al. · Neuro-Oncology · 1
Rab35 drives the malignant progression of endometrial carcinoma by regulating the nuclear translocation of β-catenin
2026 · Eryan Yang, Yindan Wang, et al. · Experimental Cell Research · 1
PEAKS activation by PROTAC EPIC-0726 potentiates temozolomide in glioblastoma via K63/K48 ubiquitination-dependent ERK/AKT suppression and p21 stabilization
2025 · Biao Hong, Dongyuan Su, et al. · Neuro-Oncology · 1
Retraction Notice to: Precise editing of FGFR3-TACC3 fusion genes with CRISPR-Cas13a in glioblastoma
2024 · Ye Wu, Weili Jin, et al. · Molecular Therapy
Retraction of “Universal theranostic CRISPR/Cas13a RNA-editing system for glioma”
2024 · Ye Wu, Yunfei Wang, et al. · Theranostics
PDF
Works count: 21
Citation count: 756
H-index: 12
I10-index: 12
Year
Topic
Type